2. Search Result
Search Result
Results for "

Pembrolizumab

" in MedChemExpress (MCE) Product Catalog:

4

Inhibitors & Agonists

1

Peptides

4

Inhibitory Antibodies

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P9902
    Pembrolizumab
    5+ Cited Publications

    MK-3475; Lambrolizumab

    		 PD-1/PD-L1 Cancer
    Pembrolizumab (MK-3475) is a humanized IgG4 antibody inhibiting the programmed cell death 1 (PD-1) receptor, used in cancer immunotherapy.
    <em>Pembrolizumab</em>
  • HY-P9902A
    Pembrolizumab (anti-PD-1)
    2 Publications Verification

    		 PD-1/PD-L1 Cancer
    Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody and PD-1 inhibitor. Pembrolizumab produces PD-1 blockade, preventing PD-L1 and PD-L2 from connecting to PD-1. This avoids the uncontrolled regulation of T cells on cells that normally express PD-1 .
    <em>Pembrolizumab</em> (anti-PD-1)
  • HY-P99613
    Favezelimab

    MK-4280

    		 LAG-3 Cancer
    Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab (HY-P9902) .
    Favezelimab
  • HY-P99809
    Quavonlimab

    MK-1308

    		 CTLA-4 Cancer
    Quavonlimab (MK-1308) is a novel anti-CTLA-4 antibody .
    Quavonlimab

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: